Next Generation Vaccines

Venue: Hilton Vienna Hotel

Location: Vienna, Austria

Event Date/Time: Oct 21, 2010 End Date/Time: Oct 22, 2010
Report as Spam

Description

How to overcome challenges in developing & launching most promising vaccine candidates and achieve a competitive advantage in attractive markets? How are industry, payers, governments & regulators preparing for the next pandemic influenza?

Reveal the most powerful tools to improve vaccine quality, safety, compliance, costs, supply and speed. Understand how to reach the approval and fit in the regulatory background. Be a part of the interactive workshop on Accelerated Vaccine Introduction to achieve excellence in time-to-market. Explore the leading trends in the industry and how to walk through the whole Vaccine Value Chain successfully.

Leading Pharma companies will share their experiences & achievements in conducting clinical trials. Learn from the best practices on the pathway from production to procurement. Gain first hand information on financing strategies and discuss how to make vaccine development lucrative. Maximize vaccine availability and affordability through strategic collaborations.

We bring you the senior vaccine industry experts to benchmark, how successful they are in utilizing the full potential of vaccine markets.

Venue

Additional Information

PRE-CONFERENCE WORKSHOP SESSIONS - 20th of October Several workshops during this day will provide an interactive platform designed to assist participants in acquiring practical skills and knowledge about the areas covered. All presenters are industry professionals, with extensive experience. The sessions are structured in a way to provide a useful experience underlined by real life case studies and lively benchmarking discussions. WORKSHOP SESSION #1: Accelerating Process Development – Do it right from the beginning WORKSHOP SESSION #2: Best practices in proof-of concept clinical trials and vaccine conditioning – Continue with the goal in mind WORKSHOP SESSION #3: Vaccine manufacturing challenges – A vision for the future Key speakers: * Novartis Vaccines and Diagnostics, Head of Viral Advanced Programs Global Project Team * Sanofi Pasteur, Senior Director of External R&D * Merck & Co., Director of Viral Vaccine Research * Intercell AG, Chief Executive Officer * Crucell, Chief Medical Officer * GE Healthcare, Director of Vaccines R&D * Abbott Biologicals, Head of Global Regulatory Affairs of Vaccines * WHO, Director of Vaccine Project Optimization * PATH, Vaccine Development Director * International Aids Vaccine Initiative, Director New Alliances and Initiatives, R&D Expert Advisors: * GSK Biologicals, Vice President for Emerging Diseases & HIV * Novartis Vaccines and Diagnostics, Head of Viral Advanced Programs Global Project Team * Sanofi Pasteur, Head of Influenza R&D * GE Healthcare, Director of Vaccines R&D * Genticel, Chief Executive Officer * Crucell, Senior Director Medical Affairs * WHO, Director of Vaccine Project Optimization * PATH, Vaccine Development Director * GAVI, Head of Accelerated Vaccine Introduction * HRSA, Head of Vaccine Injury Compensation Program

Types